Tradestie Institutional Equity Comparison Engine

SVRA vs ANL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SVRA Overall Edge

SVRA Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Savara Inc. (SVRA) driven by superior Valuation, Growth & Margin, Options & Structure while ANL counters with relative strength in Momentum & Technical. Fundamentally, SVRA trades at 0.4x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ANL at N/M Forward P/E and -123.5% operating margin (+178.1% YoY). In options structure, SVRA sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against ANL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SVRA
SVRA 0.4x vs ANL N/M Fwd P/E
Growth & Margin Winner SVRA
Op Margin 0.0% vs -123.5% ยท YoY +0.0% vs +178.1%
Momentum & Technical Winner ANL
1Y +3.9% vs +560.3% ยท 52W Pos 13% vs 56%
Options & Structure Winner SVRA
BREAKDOWN (17th %ile IV) vs UNCLASSIFIED (N/A IV)
SVRA NASDAQ
Savara Inc.
Pharmaceutical Preparations
$4.42
-4.63% 1D
Market Cap $1.1B
1M Return -0.56%
1Y Return +3.87%
Forward P/E 0.4x
Unified AI Score
55.6 / 100 HOLD
Tech 30.0 Fund 54.0 Flow 70.0 Mom 54.0
ANL US Equity
ANL
Institutional Equity
$9.97
-6.03% 1D
Market Cap $677.5M
1M Return -9.61%
1Y Return +560.26%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SVRA +3.87% ANL +560.26% Spread: +556.39 pp (ANL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SVRA TTM Op. Margin: 0.0% ANL TTM Op. Margin: -123.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SVRA vs ANL. Trailing 12-month operating profitability (SVRA 0.0% vs ANL -123.5%) and valuation multiples (SVRA 0.4x vs ANL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SVRA (7) vs ANL (3)
Institutional Metric SVRA ANL Criterion Row Winner
Market Capitalization Scale $1.1B $677.5M Larger Scale SVRA
Trailing P/E Ratio Valuation 0.4x N/M Lower Multiple SVRA
Forward P/E Ratio Valuation 0.4x N/M Lower Multiple SVRA
Revenue Growth (YoY) Growth +0.0% +178.1% Higher Growth ANL
Operating Margin (TTM) Profitability 0.0% -123.5% Higher Margin SVRA
Net Profit Margin Profitability 0.0% -124.8% Higher Margin SVRA
Return on Equity (ROE) Capital Efficiency -151.0% -20.2% Higher ROE ANL
52-Week Range Position Momentum 13% ($4โ€“$7) 56% ($1โ€“$17) Stronger Trend ANL
Beta / 30D Volatility Risk Regime 1.48ฮฒ ยท 73% Vol 2.61ฮฒ ยท 79% Vol Lower Realized Risk SVRA
Unified Institutional Score Composite Signal 55.6 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite SVRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SVRA vs ANL Buy Guide
SVRA BREAKDOWN
92d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live SVRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ANL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SVRA nor ANL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.